Option Care Health (OPCH) Expected to Announce Quarterly Earnings on Wednesday

Option Care Health (NASDAQ:OPCH) is expected to announce its earnings results before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.33 per share and revenue of $1.29 billion for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $32.00 on Monday. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63. The business has a 50-day moving average of $27.71 and a 200-day moving average of $27.97. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a market capitalization of $5.45 billion, a price-to-earnings ratio of 26.89, a PEG ratio of 2.30 and a beta of 1.35.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on OPCH shares. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and upped their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group started coverage on Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price for the company. JPMorgan Chase & Co. increased their price target on Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, January 24th. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Finally, JMP Securities reissued a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $32.25.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.